SK279471B6 - Kompozícia zlúčenín, farmaceutické prostriedky s i - Google Patents

Kompozícia zlúčenín, farmaceutické prostriedky s i Download PDF

Info

Publication number
SK279471B6
SK279471B6 SK1225-95A SK122595A SK279471B6 SK 279471 B6 SK279471 B6 SK 279471B6 SK 122595 A SK122595 A SK 122595A SK 279471 B6 SK279471 B6 SK 279471B6
Authority
SK
Slovakia
Prior art keywords
aids
hiv
composition
compound
arc
Prior art date
Application number
SK1225-95A
Other languages
English (en)
Slovak (sk)
Other versions
SK122595A3 (en
Inventor
Joseph P. Vacca
James P. Guare
Bruce D. Dorsey
M. Katharine Holloway
Randall W. Hungate
Original Assignee
Merck & Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co. filed Critical Merck & Co.
Publication of SK122595A3 publication Critical patent/SK122595A3/sk
Publication of SK279471B6 publication Critical patent/SK279471B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK1225-95A 1993-03-31 1994-03-24 Kompozícia zlúčenín, farmaceutické prostriedky s i SK279471B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4072993A 1993-03-31 1993-03-31
PCT/US1994/003209 WO1994022480A1 (en) 1993-03-31 1994-03-24 Hiv protease inhibitors in pharmaceutical combinations for the treatment of aids

Publications (2)

Publication Number Publication Date
SK122595A3 SK122595A3 (en) 1997-03-05
SK279471B6 true SK279471B6 (sk) 1998-11-04

Family

ID=21912617

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1225-95A SK279471B6 (sk) 1993-03-31 1994-03-24 Kompozícia zlúčenín, farmaceutické prostriedky s i

Country Status (34)

Country Link
EP (1) EP0617968B1 (de)
JP (1) JPH08508496A (de)
KR (1) KR100311551B1 (de)
CN (1) CN1090186C (de)
AT (1) ATE230610T1 (de)
AU (1) AU685772B2 (de)
BG (1) BG62083B1 (de)
BR (1) BR9406503A (de)
CA (1) CA2120192A1 (de)
CY (1) CY2326B1 (de)
CZ (1) CZ286412B6 (de)
DE (1) DE69431972T2 (de)
DK (1) DK0617968T3 (de)
DZ (1) DZ1766A1 (de)
ES (1) ES2188604T3 (de)
FI (1) FI954580A7 (de)
HR (1) HRP940209B1 (de)
HU (1) HUT74006A (de)
IL (1) IL109166A (de)
LV (1) LV13141B (de)
NO (1) NO953876L (de)
NZ (1) NZ265164A (de)
PL (1) PL310895A1 (de)
PT (1) PT617968E (de)
RO (1) RO118000B1 (de)
RU (1) RU2139052C1 (de)
SA (1) SA94140745B1 (de)
SG (1) SG64366A1 (de)
SI (1) SI9420017B (de)
SK (1) SK279471B6 (de)
TW (1) TW307684B (de)
WO (1) WO1994022480A1 (de)
YU (1) YU49275B (de)
ZA (1) ZA942255B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2174921T3 (es) * 1993-12-15 2002-11-16 Merck & Co Inc Inhibidores de la proteasa del vih.
UA49803C2 (uk) * 1994-06-03 2002-10-15 Дж.Д. Сьорль Енд Ко Спосіб лікування ретровірусних інфекцій
US5476874A (en) * 1994-06-22 1995-12-19 Merck & Co., Inc. New HIV protease inhibitors
WO1996012492A1 (en) * 1994-10-25 1996-05-02 Merck & Co., Inc. Microbial synthesis of hiv protease inhibitors
US6689761B1 (en) 1995-02-01 2004-02-10 Merck & Co., Inc. Combination therapy for HIV infection
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
PE11499A1 (es) * 1997-05-16 1999-03-01 Procter & Gamble Tratamiento del hiv y cancer
HU9701081D0 (en) * 1997-06-23 1997-08-28 Gene Research Lab Inc N Pharmaceutical composition of antitumoral activity
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
EP1095022A1 (de) 1998-07-08 2001-05-02 G.D. Searle & Co. Inhibitoren von retoviraler protease
AU6508899A (en) 1998-10-13 2000-05-01 Du Pont Pharmaceuticals Company Selective eradication of virally-infected cells by combined use of a cytotoxic agent and an antiviral agent
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US7868037B2 (en) 2004-07-14 2011-01-11 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7772271B2 (en) 2004-07-14 2010-08-10 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
EA200700243A1 (ru) 2004-07-14 2007-08-31 ПиТиСи ТЕРАПЬЮТИКС, ИНК. Способы лечения гепатита с
EP1781289A1 (de) 2004-07-22 2007-05-09 PTC Therapeutics, Inc. Thienopyridine zur behandlung von hepatitis c
RU2281297C2 (ru) * 2004-08-23 2006-08-10 Государственное учреждение Научно-исследовательский институт вирусологии им. Д.И. Ивановского Российской академии медицинских наук Полианионные производные норборнана, способ получения и ингибиторы репродукции вируса иммунодефицита человека на их основе
RU2520967C1 (ru) * 2013-02-08 2014-06-27 Федеральное государственное бюджетное учреждение науки Новосибирский институт органической химии им. Н.Н. Ворожцова Сибирского отделения Российской академии наук (НИОХ СО РАН) СИММЕТРИЧНЫЕ ДИИМИНЫ НА ОСНОВЕ КАМФОРЫ - ИНГИБИТОРЫ РЕПРОДУКЦИИ ВИРУСА ГРИППА (ШТАММ A/California/07/09 (H1N1)pdm09)
CN109528747A (zh) * 2018-12-13 2019-03-29 中国人民解放军总医院 扎西他滨在制备抗菌消炎药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
IL89900A0 (en) * 1988-04-12 1989-12-15 Merck & Co Inc Hiv protease inhibitors useful for the treatment of aids and pharmaceutical compositions containing them
CA2032259A1 (en) * 1989-12-18 1991-06-19 Wayne J. Thompson Hiv protease inhibitors useful for the treatment of aids
WO1992004374A1 (fr) * 1990-09-11 1992-03-19 Seikagaku Kogyo Co., Ltd. Nouveau polypeptide et medicament anti-vih prepare a partir de ce polypeptide
IL99843A0 (en) * 1990-11-01 1992-08-18 Merck & Co Inc Synergistic combination of hiv reverse transcriptase inhibitors
JPH06508146A (ja) * 1991-06-04 1994-09-14 スミスクライン・ビーチャム・コーポレイション 炭素環および複素環式ｈｉｖプロテアーゼ抑制剤

Also Published As

Publication number Publication date
HRP940209A2 (en) 1998-02-28
SK122595A3 (en) 1997-03-05
ATE230610T1 (de) 2003-01-15
PT617968E (pt) 2003-03-31
DE69431972D1 (de) 2003-02-13
HU9502860D0 (en) 1995-11-28
NO953876D0 (no) 1995-09-29
SI9420017A (en) 1996-10-31
PL310895A1 (en) 1996-01-08
CN1120316A (zh) 1996-04-10
TW307684B (de) 1997-06-11
HK1009248A1 (en) 1999-05-28
EP0617968B1 (de) 2003-01-08
WO1994022480A1 (en) 1994-10-13
FI954580L (fi) 1995-09-27
KR100311551B1 (ko) 2001-12-28
SA94140745B1 (ar) 2006-07-11
YU15994A (sh) 1999-06-15
CY2326B1 (en) 2003-11-14
IL109166A0 (en) 1994-06-24
FI954580A0 (fi) 1995-09-27
FI954580A7 (fi) 1995-09-27
CN1090186C (zh) 2002-09-04
RO118000B1 (ro) 2002-12-30
LV13141B (en) 2004-08-20
CA2120192A1 (en) 1994-10-01
CZ252895A3 (en) 1996-07-17
BR9406503A (pt) 1996-01-02
NO953876L (no) 1995-11-30
HRP940209B1 (en) 2004-04-30
AU5921394A (en) 1994-10-06
DK0617968T3 (da) 2003-02-24
SG64366A1 (en) 1999-04-27
BG62083B1 (bg) 1999-02-26
HUT74006A (en) 1996-10-28
NZ265164A (en) 1997-09-22
KR960701661A (ko) 1996-03-28
SI9420017B (sl) 2003-12-31
IL109166A (en) 1999-08-17
EP0617968A1 (de) 1994-10-05
DE69431972T2 (de) 2003-08-28
AU685772B2 (en) 1998-01-29
ZA942255B (en) 1994-11-01
ES2188604T3 (es) 2003-07-01
RU2139052C1 (ru) 1999-10-10
DZ1766A1 (fr) 2002-02-17
CZ286412B6 (en) 2000-04-12
YU49275B (sh) 2005-03-15
BG100016A (bg) 1996-04-30
JPH08508496A (ja) 1996-09-10

Similar Documents

Publication Publication Date Title
SK136395A3 (en) Hiv protease inhibitors and pharmaceutical composition containing them
EP0617968B1 (de) HIV Protease Hemmer in pharmazeutischen Zusammensetzungen zur Behandlung von AIDS
EP0734387B1 (de) Hiv-proteaseinhibitoren
SK52394A3 (en) Hiv protease inhibitors useful for the treatment of aids
WO1995012583A1 (en) New quinazolines as inhibitors of hiv reverse transcriptase
JP2012528160A (ja) Ｈｉｖプロテアーゼ阻害薬
CA2095194A1 (en) Quinazolines as inhibitors of hiv reverse transcriptase
US5650412A (en) HIV protease inhibitors useful for the treatment of AIDS
WO1994026749A1 (en) Hiv protease inhibitors
US5811462A (en) HIV Protease inhibitors useful for the treatment of AIDS
AU2923897A (en) Hiv protease inhibitors useful for the treatment of aids
US6589962B1 (en) Alpha-hydroxy-gamma-[[(carbocyclic-or heterocyclic-substituted)amino]carbonyl]alkanamide derivatives and uses thereof
HK1009248B (en) Hiv protease inhibitors in pharmaceutical combinations for the treatment of aids
GB2287938A (en) Conformationally restricted HIV-1 protease inhibitors
CA2375954A1 (en) Alpha-hydroxy-gamma-¬¬(carbocyclic-or heterocyclic-substituted)amino|carbonyl|alkanamide derivatives and uses thereof